Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2026-01-02 @ 6:27 AM
Study NCT ID:
NCT02836704
Status:
COMPLETED
Last Update Posted:
2022-04-25
First Post:
2016-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-26
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-07
First Submit QC Date:
None
Study First Post Date:
2016-07-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-21
Last Update Post Date:
2022-04-25
Last Update Post Date Type:
ACTUAL